EMEA-001356-PIP02-12-M04
Key facts
Invented name |
Clensia
|
Active substance |
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0134/2021
|
PIP number |
EMEA-001356-PIP02-12-M04
|
Pharmaceutical form(s) |
Powder for oral suspension
|
Condition(s) / indication(s) |
Bowel cleansing prior to clinical procedures
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Alfasigma S.p.A.
E-mail: Antonietta.Pazardjiklian@alfasigma.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001356-PIP02-12-M04
|
Compliance opinion date |
17/12/2021
|
Compliance outcome |
positive
|